Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Skin to Skin”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02565810
What this trial is testing

An Multicentre Clinical Study to Evaluate the Usability and Safety of the Pre-filled Pen and Pre-filled Syringe of SB5 in Subjects With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Samsung Bioepis Co., Ltd. 49
Testing effectiveness (Phase 2)Study completedNCT01740297
What this trial is testing

Ipilimumab With or Without Talimogene Laherparepvec in Unresected Melanoma

Who this might be right for
Melanoma
Amgen 217
Not applicableEnrolling By InvitationNCT06328010
What this trial is testing

Clinical Registry Collecting Real World Evidence on Wound Care Treatments

Who this might be right for
Wounds and InjuriesBurnsMohs Surgery+7 more
Siddhey LLC 5,000
Large-scale testing (Phase 3)Study completedNCT00122382
What this trial is testing

Remission and Joint Damage Progression in Early Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 1,052
Testing effectiveness (Phase 2)Ended earlyNCT04524858
What this trial is testing

Study of ATI-450 in Patients With Cryopyrin-Associated Periodic Syndrome (CAPS)

Who this might be right for
Cryopyrin-Associated Periodic Syndrome
Aclaris Therapeutics, Inc. 1
Testing effectiveness (Phase 2)Study completedNCT01397708
What this trial is testing

Safety Study of Adenovirus Vector Engineered to Express hIL-12 in Combination With Activator Ligand to Treat Melanoma

Who this might be right for
Melanoma
Alaunos Therapeutics 26
Early research (Phase 1)Study completedNCT03306589
What this trial is testing

Lipopolysaccharide (LPS) or Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Challenge Study on Healthy Subjects

Who this might be right for
Arthritis, Rheumatoid
GlaxoSmithKline 12
Not applicableStudy completedNCT06603168
What this trial is testing

Autonomic Recalibration

Who this might be right for
Chronic Pain (Back / Neck)Autonomic Dysregulation
Edward Via Virginia College of Osteopathic Medicine 20
Large-scale testing (Phase 3)Looking for participantsNCT06775860
What this trial is testing

ICP-332 in Subjects With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Beijing InnoCare Pharma Tech Co., Ltd. 552
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07367178
What this trial is testing

Study of Sacituzumab Govitecan With Atropine to Improve Tolerability in Advanced TNBC and HR+/HER2- Breast Cancer

Who this might be right for
Breast CancerAdvanced HR+/HER2- Breast CancerAdvanced Triple-Negative Breast Cancer
MedSIR 30
Early research (Phase 1)Study completedNCT00425178
What this trial is testing

FGF-1 for Topical Administration for the Treatment of Diabetic or Venous Stasis Ulcers

Who this might be right for
Chronic WoundsDiabetesVenous Stasis Ulcers
Venturis Therapeutics, Inc. 8
Not applicableLooking for participantsNCT05251415
What this trial is testing

Clinico-biological Collection to Investigate the Physiopathology of Systemic Autoimmune Diseases

Who this might be right for
Lupus ErythematosusSclerodermaMyositis+2 more
University Hospital, Toulouse 3,000
Not applicableActive Not RecruitingNCT02276443
What this trial is testing

Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer Receiving Chemotherapy MDACC Breast Moonshot Initiative

Who this might be right for
Invasive Breast CarcinomaStage I Breast Cancer AJCC v7Stage IA Breast Cancer AJCC v7+9 more
M.D. Anderson Cancer Center 798
Large-scale testing (Phase 3)Study completedNCT00767325
What this trial is testing

A Rheumatoid Arthritis Study to Assess Early Response to Abatacept+MTX as Defined by Improvement of Synovitis Measures by Power Doppler Ultrasonography

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 104
Early research (Phase 1)Study completedNCT01702740
What this trial is testing

The Safety and Pharmacokinetics of CNTO 136 in Patients With Cutaneous Lupus Erythematosus and Systemic Lupus Erythematosus

Who this might be right for
Lupus Erythematosus, CutaneousLupus Erythematosus, Systemic
Centocor Research & Development, Inc. 49
Not applicableStudy completedNCT02612168
What this trial is testing

Melanoma Image Analysis Algorithm (MIAA) Validation Study

Who this might be right for
Malignant Melanoma
Skin Analytics Limited 514
Early research (Phase 1)Study completedNCT03150810
What this trial is testing

Study to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Participants With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid Tumors
BeiGene 139
Large-scale testing (Phase 3)Not Yet RecruitingNCT07579910
What this trial is testing

Intracerebroventricular Tralesinidase Alfa in Participants With MPS IIIB (Sanfilippo Syndrome Type B)

Who this might be right for
MPS IIIB
Spruce Biosciences 14
Testing effectiveness (Phase 2)Study completedNCT04152226
What this trial is testing

A Trial to Evaluate the Safety and and Tolerability of DBI-001 in Patients With Tinea Pedis

Who this might be right for
Tinea Pedis
DermBiont, Inc. 12
Not applicableStudy completedNCT01361035
What this trial is testing

Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients

Who this might be right for
Cervical CancerBreast CancerColorectal Cancer
Tulane University School of Medicine 168
Next Page